Saturday, July 24
Auditorium – 11:00am – Retinopathy: Why LCHADD & Eye Health
About the Speaker
Dr. Tiffany DeVine is a post doctoral scholar in Dr. Melanie Gillingham’s lab in the department of Molecular and Medical Genetics at Oregon Health and Science University. Her work has focused on developing and characterizing a cell model of long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) associated retinopathy using patient derived induced pluripotent stem cells (iPSCs).